Brief: Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
05/01/2024 22:18
Jan 5 (Reuters) - Xeris Biopharma Holdings Inc XERS.O :
* XERIS PHARMACEUTICALS ANNOUNCES INDUCEMENT GRANTS UNDER
NASDAQ
LISTING RULE 5635(C)(4)
Source text for Eikon: ID:nBw8PhZLVa
Further company coverage: XERS.O
Recent news on Xeris Biopharma Holdings
See all newsBrief: Xeris Biopharma Announces Private Exchange Of Convertible Notes
Xeris Biopharma Q1 product revenue jumps 43%, beats estimates
Brief: Xeris Biopharma Q4 Product Revenue USD 83.43 Million Versus. Ibes Estimate USD 82.3 Million
Xeris Biopharma Q4 product revenue beats analyst expectations, driven by higher patient demand
Brief: Xeris Biopharma Subsidiaries File Recorlev Patent Infringement Lawsuit